The Molecular Intersection Between Senescence and Major Depression in the Elderly

Area of Science:

• Gerontology
• Cellular Biology
• Psychiatry

Background:

• Late-life depression (LLD) is a prevalent mental illness in older adults.
• LLD is associated with adverse health outcomes, including cognitive decline, medical comorbidity, frailty, and mortality.
• The underlying mechanisms connecting LLD to these negative health outcomes are not fully understood.

Purpose of the Study:

• To review evidence linking LLD to enhanced cellular senescence and the senescence-associated secretory phenotype (SASP).
• To propose a mechanistic model connecting SASP to adverse health outcomes in LLD.
• To explore SASP and cellular senescence as potential therapeutic targets for LLD.

Main Methods:

• Review of existing scientific literature on LLD, cellular senescence, and SASP.
• Development of a mechanistic model illustrating the link between SASP and LLD-associated health risks.
• Examination of evidence supporting cellular senescence as a therapeutic target.

Main Results:

• Individuals with LLD exhibit enhanced molecular and cellular senescent changes, including SASP.
• SASP is proposed as a key mediator linking LLD to increased risks of cognitive impairment, medical comorbidity, frailty, and mortality.
• Evidence suggests that targeting SASP and cellular senescence could be a viable therapeutic strategy for LLD.

Conclusions:

• Cellular senescence, particularly SASP, plays a significant role in the pathophysiology of LLD and its associated health consequences.
• Targeting cellular senescence presents a promising novel therapeutic avenue for managing LLD and improving health outcomes in the elderly.
• Further research into SASP modulation is warranted for LLD treatment development.